Major bleeding complications in cardiopulmonary resuscitation:: the place of thrombolytic therapy in cardiac arrest due to massive pulmonary embolism

Objective: Thrombolytic therapy in patients with massive pulmonary embolism (MPE) and prolonged cardiopulmonary resuscitation (CPR) is subject to debate. This study was performed to determine whether (1) thrombolytic treatment increases the risk of bleeding complications, (2) if the risk of bleeding is influenced by the duration of CPR and if (3) thrombolytic therapy improves outcome. Design: Retrospective cohort study. Setting: Emergency department of a tertiary care university hospital. Patients and methods. Sixty-six patients with cardiac arrest (CA) due to MPE admitted between July 1993 and December 2001. Thirty-six patients received thrombolysis (TL) and were compared with 30 patients without thrombolytic therapy. Bleeding complications were assessed by clinical evidence or autopsy. Results: Major bleeding complications appear to occur more frequently in patients treated with thrombolytics (9/36 (25%) vs. 3/30 (10%)) even though the difference was statistically not significant (P = 0.15). It appears that CPR duration > 10 min has no adverse impact on major bleeding complications. No difference in the rate of major bleeding complications between thrombolyzed patients who had a CPR duration of less than or equal to 10 or > 10 min could be observed (2/8 (25%) vs. 7/28 (25%), P = 0.99). In thrombolyzed patients a return of spontaneous circulation could be achieved more frequently (24/36 (67%) vs. 13/30 (43%) in controls, P = 0.06) and survival after 24 h was higher (19/36 (53%) vs. 7/30 (23%), P = 0.01). Survival to discharge was also higher in the TL group (7/36 (19%) vs. 2/30 (7%)), but not statistically significant (P = 0.15). Conclusion: Although severe bleeding complications tend to occur more frequently in patients undergoing TL, the benefit of this treatment might outweigh the risk of bleeding. (C) 2003 Elsevier Science Ireland Ltd. All rights reserved.